APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sorafenib Tablet

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sorafenib Tablet Industry Growth and Trends Forecast to 2032

Report ID 174037060128 December 202598 pages

Choose your research edition.

Industry ResearchSorafenib Tablet Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Sorafenib Tablet Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sorafenib Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sorafenib Tablet Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Sorafenib Tablet Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Sorafenib Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sorafenib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sorafenib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sorafenib Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sorafenib Tablet include Teva, Mylan, Bayer, Natco Pharma, MBA Pharmaceuticals Pvt Ltd, healthiza, Cipla, Aprazer and Aetos Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sorafenib Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sorafenib Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sorafenib Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sorafenib Tablet.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sorafenib Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sorafenib Tablet Market by Company

Teva

Mylan

Bayer

Natco Pharma

MBA Pharmaceuticals Pvt Ltd

healthiza

Cipla

Aprazer

Aetos Pharma

Sorafenib Tablet Segment by Type

Patented Drugs

Generic Drugs

Sorafenib Tablet Segment by Application

Kidney Cancer

Other

Thyroid Cancer

Liver Cancer

Sorafenib Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sorafenib Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sorafenib Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sorafenib Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sorafenib Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sorafenib Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Patented Drugs Table 2. Major Company of Generic Drugs Table 3. Global Sorafenib Tablet Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 5. Global Sorafenib Tablet Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sorafenib Tablet Sales Market Share in Value by Type (2021-2026) Table 8. Global Sorafenib Tablet Price by Type (2021-2026) & (US$/Unit) Table 9. Global Sorafenib Tablet Sales by Type (2027-2032) & (K Units) Table 10. Global Sorafenib Tablet Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sorafenib Tablet Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sorafenib Tablet Sales Market Share in Value by Type (2027-2032) Table 13. Global Sorafenib Tablet Price by Type (2027-2032) & (US$/Unit) Table 14. North America Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 15. North America Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 17. Europe Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 21. Latin America Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sorafenib Tablet Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Sorafenib Tablet Sales by Type (2021-2026) & (US$ Million) Table 24. Sorafenib Tablet Industry Trends Table 25. Sorafenib Tablet Industry Drivers Table 26. Sorafenib Tablet Industry Opportunities and Challenges Table 27. Sorafenib Tablet Industry Restraints Table 28. Global Sorafenib Tablet Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sorafenib Tablet Revenue Market Share by Company (2021-2026) Table 30. Global Sorafenib Tablet Sales by Company (2021-2026) & (K Units) Table 31. Global Sorafenib Tablet Sales Share by Company (2021-2026) Table 32. Global Sorafenib Tablet Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Sorafenib Tablet Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sorafenib Tablet Major Company Production Sites and Headquarters Table 35. Global Sorafenib Tablet Company, Product Type & Application Table 36. Global Sorafenib Tablet Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sorafenib Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sorafenib Tablet Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sorafenib Tablet Sales by Region (2021-2026) & (K Units) Table 41. Global Sorafenib Tablet Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sorafenib Tablet Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sorafenib Tablet Sales Market Share in Value by Region (2021-2026) Table 44. Global Sorafenib Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Sorafenib Tablet Sales by Region (2027-2032) & (K Units) Table 46. Global Sorafenib Tablet Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sorafenib Tablet Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sorafenib Tablet Sales Market Share in Value by Region (2027-2032) Table 49. Global Sorafenib Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Sorafenib Tablet Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 52. Global Sorafenib Tablet Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sorafenib Tablet Sales Market Share in Value by Application (2021-2026) Table 55. Global Sorafenib Tablet Price by Application (2021-2026) & (US$/Unit) Table 56. Global Sorafenib Tablet Sales by Application (2027-2032) & (K Units) Table 57. Global Sorafenib Tablet Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sorafenib Tablet Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sorafenib Tablet Sales Market Share in Value by Application (2027-2032) Table 60. Global Sorafenib Tablet Price by Application (2027-2032) & (US$/Unit) Table 61. North America Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 62. North America Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 64. Europe Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 68. Latin America Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sorafenib Tablet Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Sorafenib Tablet Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Sorafenib Tablet Product Portfolio Table 75. Teva Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Sorafenib Tablet Product Portfolio Table 80. Mylan Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bayer Sorafenib Tablet Product Portfolio Table 85. Bayer Recent Development Table 86. Natco Pharma Company Information Table 87. Natco Pharma Business Overview Table 88. Natco Pharma Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Natco Pharma Sorafenib Tablet Product Portfolio Table 90. Natco Pharma Recent Development Table 91. MBA Pharmaceuticals Pvt Ltd Company Information Table 92. MBA Pharmaceuticals Pvt Ltd Business Overview Table 93. MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Portfolio Table 95. MBA Pharmaceuticals Pvt Ltd Recent Development Table 96. healthiza Company Information Table 97. healthiza Business Overview Table 98. healthiza Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. healthiza Sorafenib Tablet Product Portfolio Table 100. healthiza Recent Development Table 101. Cipla Company Information Table 102. Cipla Business Overview Table 103. Cipla Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Cipla Sorafenib Tablet Product Portfolio Table 105. Cipla Recent Development Table 106. Aprazer Company Information Table 107. Aprazer Business Overview Table 108. Aprazer Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Aprazer Sorafenib Tablet Product Portfolio Table 110. Aprazer Recent Development Table 111. Aetos Pharma Company Information Table 112. Aetos Pharma Business Overview Table 113. Aetos Pharma Sorafenib Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Aetos Pharma Sorafenib Tablet Product Portfolio Table 115. Aetos Pharma Recent Development Table 116. North America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Sorafenib Tablet Sales by Country (2021-2026) & (K Units) Table 118. North America Sorafenib Tablet Sales Market Share by Country (2021-2026) Table 119. North America Sorafenib Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Sorafenib Tablet Sales Market Share Forecast by Country (2027-2032) Table 121. North America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Sorafenib Tablet Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Sorafenib Tablet Market Share by Country (2021-2026) Table 124. North America Sorafenib Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Sorafenib Tablet Market Share Forecast by Country (2027-2032) Table 126. Europe Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Sorafenib Tablet Sales by Country (2021-2026) & (K Units) Table 128. Europe Sorafenib Tablet Sales Market Share by Country (2021-2026) Table 129. Europe Sorafenib Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Sorafenib Tablet Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Sorafenib Tablet Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Sorafenib Tablet Market Share by Country (2021-2026) Table 134. Europe Sorafenib Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Sorafenib Tablet Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Sorafenib Tablet Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Sorafenib Tablet Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Sorafenib Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Sorafenib Tablet Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Sorafenib Tablet Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Sorafenib Tablet Market Share by Country (2021-2026) Table 144. Asia-Pacific Sorafenib Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Sorafenib Tablet Market Share Forecast by Country (2027-2032) Table 146. Latin America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Sorafenib Tablet Sales by Country (2021-2026) & (K Units) Table 148. Latin America Sorafenib Tablet Sales Market Share by Country (2021-2026) Table 149. Latin America Sorafenib Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Sorafenib Tablet Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Sorafenib Tablet Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Sorafenib Tablet Market Share by Country (2021-2026) Table 154. Latin America Sorafenib Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Sorafenib Tablet Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Sorafenib Tablet Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Sorafenib Tablet Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Sorafenib Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Sorafenib Tablet Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Sorafenib Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Sorafenib Tablet Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Sorafenib Tablet Market Share by Country (2021-2026) Table 164. Middle East and Africa Sorafenib Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Sorafenib Tablet Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Sorafenib Tablet Distributors List Table 169. Sorafenib Tablet Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Sorafenib Tablet Image Figure 2. Global Sorafenib Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sorafenib Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Sorafenib Tablet Sales (2021-2032) & (K Units) Figure 5. Patented Drugs Image Figure 6. Global Patented Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drugs Image Figure 8. Global Generic Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Sorafenib Tablet Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sorafenib Tablet Market Share by Type 2025 VS 2032 Figure 11. North America Sorafenib Tablet Sales Market Share in Volume by Type in 2025 Figure 12. North America Sorafenib Tablet Sales Market Share in Value by Type in 2025 Figure 13. Europe Sorafenib Tablet Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sorafenib Tablet Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sorafenib Tablet Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sorafenib Tablet Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sorafenib Tablet Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sorafenib Tablet Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sorafenib Tablet Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sorafenib Tablet Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sorafenib Tablet Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Kidney Cancer Image Figure 24. Global Kidney Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Other Image Figure 26. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 27. Thyroid Cancer Image Figure 28. Global Thyroid Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Liver Cancer Image Figure 30. Global Liver Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Sorafenib Tablet Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sorafenib Tablet Market Share by Application 2025 VS 2032 Figure 33. North America Sorafenib Tablet Sales Market Share in Volume by Application in 2025 Figure 34. North America Sorafenib Tablet Sales Market Share in Value by Application in 2025 Figure 35. Europe Sorafenib Tablet Sales Market Share in Volume by Application in 2025 Figure 36. Europe Sorafenib Tablet Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Sorafenib Tablet Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Sorafenib Tablet Sales Market Share in Value by Application in 2025 Figure 39. Latin America Sorafenib Tablet Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Sorafenib Tablet Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Sorafenib Tablet Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Sorafenib Tablet Sales Market Share in Value by Application in 2025 Figure 43. North America Sorafenib Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Sorafenib Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Sorafenib Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Sorafenib Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sorafenib Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Sorafenib Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sorafenib Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Sorafenib Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sorafenib Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Sorafenib Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sorafenib Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Sorafenib Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sorafenib Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Sorafenib Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sorafenib Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Sorafenib Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sorafenib Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Sorafenib Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sorafenib Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Sorafenib Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Sorafenib Tablet Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Sorafenib Tablet Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Patented Drugs
  • Generic Drugs
Applications
  • Kidney Cancer
  • Other
  • Thyroid Cancer
  • Liver Cancer
Companies covered
  • Teva
  • Mylan
  • Bayer
  • Natco Pharma
  • MBA Pharmaceuticals Pvt Ltd
  • healthiza
  • Cipla
  • Aprazer
  • Aetos Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sorafenib Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sorafenib Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sorafenib Tablet Market by Type
  6. 1.3.1 Patented Drugs
  7. 1.3.2 Generic Drugs
  8. 1.4 Global Sorafenib Tablet Market Size by Type
  9. 1.4.1 Global Sorafenib Tablet Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sorafenib Tablet Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sorafenib Tablet Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sorafenib Tablet Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sorafenib Tablet Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sorafenib Tablet Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sorafenib Tablet Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sorafenib Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sorafenib Tablet Industry Trends
  2. 2.2 Sorafenib Tablet Industry Drivers
  3. 2.3 Sorafenib Tablet Industry Opportunities and Challenges
  4. 2.4 Sorafenib Tablet Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sorafenib Tablet Revenue (2021-2026)
  2. 3.2 Global Top Players by Sorafenib Tablet Sales (2021-2026)
  3. 3.3 Global Top Players by Sorafenib Tablet Price (2021-2026)
  4. 3.4 Global Sorafenib Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sorafenib Tablet Major Company Production Sites & Headquarters
  6. 3.6 Global Sorafenib Tablet Company, Product Type & Application
  7. 3.7 Global Sorafenib Tablet Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sorafenib Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sorafenib Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sorafenib Tablet Tier 1, Tier 2, and Tier 3
4 Sorafenib Tablet Regional Status and Outlook
  1. 4.1 Global Sorafenib Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sorafenib Tablet Historic Market Size by Region
  3. 4.2.1 Global Sorafenib Tablet Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sorafenib Tablet Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sorafenib Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sorafenib Tablet Forecasted Market Size by Region
  7. 4.3.1 Global Sorafenib Tablet Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sorafenib Tablet Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sorafenib Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sorafenib Tablet by Application
  1. 5.1 Sorafenib Tablet Market by Application
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Other
  4. 5.1.3 Thyroid Cancer
  5. 5.1.4 Liver Cancer
  6. 5.2 Global Sorafenib Tablet Market Size by Application
  7. 5.2.1 Global Sorafenib Tablet Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Sorafenib Tablet Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Sorafenib Tablet Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Sorafenib Tablet Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Sorafenib Tablet Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Sorafenib Tablet Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Sorafenib Tablet Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Sorafenib Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Sorafenib Tablet Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Sorafenib Tablet Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Sorafenib Tablet Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Natco Pharma
  20. 6.4.1 Natco Pharma Company Information
  21. 6.4.2 Natco Pharma Business Overview
  22. 6.4.3 Natco Pharma Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Natco Pharma Sorafenib Tablet Product Portfolio
  24. 6.4.5 Natco Pharma Recent Developments
  25. 6.5 MBA Pharmaceuticals Pvt Ltd
  26. 6.5.1 MBA Pharmaceuticals Pvt Ltd Company Information
  27. 6.5.2 MBA Pharmaceuticals Pvt Ltd Business Overview
  28. 6.5.3 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Portfolio
  30. 6.5.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
  31. 6.6 healthiza
  32. 6.6.1 healthiza Company Information
  33. 6.6.2 healthiza Business Overview
  34. 6.6.3 healthiza Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 healthiza Sorafenib Tablet Product Portfolio
  36. 6.6.5 healthiza Recent Developments
  37. 6.7 Cipla
  38. 6.7.1 Cipla Company Information
  39. 6.7.2 Cipla Business Overview
  40. 6.7.3 Cipla Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cipla Sorafenib Tablet Product Portfolio
  42. 6.7.5 Cipla Recent Developments
  43. 6.8 Aprazer
  44. 6.8.1 Aprazer Company Information
  45. 6.8.2 Aprazer Business Overview
  46. 6.8.3 Aprazer Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aprazer Sorafenib Tablet Product Portfolio
  48. 6.8.5 Aprazer Recent Developments
  49. 6.9 Aetos Pharma
  50. 6.9.1 Aetos Pharma Company Information
  51. 6.9.2 Aetos Pharma Business Overview
  52. 6.9.3 Aetos Pharma Sorafenib Tablet Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aetos Pharma Sorafenib Tablet Product Portfolio
  54. 6.9.5 Aetos Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Sorafenib Tablet Sales by Country
  2. 7.1.1 North America Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sorafenib Tablet Sales by Country (2021-2026)
  4. 7.1.3 North America Sorafenib Tablet Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sorafenib Tablet Market Size by Country
  6. 7.2.1 North America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sorafenib Tablet Market Size by Country (2021-2026)
  8. 7.2.3 North America Sorafenib Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sorafenib Tablet Sales by Country
  2. 8.1.1 Europe Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sorafenib Tablet Sales by Country (2021-2026)
  4. 8.1.3 Europe Sorafenib Tablet Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sorafenib Tablet Market Size by Country
  6. 8.2.1 Europe Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sorafenib Tablet Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sorafenib Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sorafenib Tablet Sales by Country
  2. 9.1.1 Asia-Pacific Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sorafenib Tablet Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sorafenib Tablet Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sorafenib Tablet Market Size by Country
  6. 9.2.1 Asia-Pacific Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sorafenib Tablet Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sorafenib Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sorafenib Tablet Sales by Country
  2. 10.1.1 South America Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sorafenib Tablet Sales by Country (2021-2026)
  4. 10.1.3 South America Sorafenib Tablet Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sorafenib Tablet Market Size by Country
  6. 10.2.1 South America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sorafenib Tablet Market Size by Country (2021-2026)
  8. 10.2.3 South America Sorafenib Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sorafenib Tablet Sales by Country
  2. 11.1.1 Middle East and Africa Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sorafenib Tablet Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sorafenib Tablet Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sorafenib Tablet Market Size by Country
  6. 11.2.1 Middle East and Africa Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sorafenib Tablet Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sorafenib Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sorafenib Tablet Value Chain Analysis
  2. 12.1.1 Sorafenib Tablet Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sorafenib Tablet Production Mode & Process
  7. 12.2 Sorafenib Tablet Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sorafenib Tablet Distributors
  10. 12.2.3 Sorafenib Tablet Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst